Clinical Trials Browser

Phase 3 × Breast Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all

NCT00381901 2011-05-13

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Phase 3 Completed

Breast Neoplasms